Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q2 EPS by 10c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q2 EPS of ($0.29), $0.10 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $2.73 million versus the consensus estimate of $3.59 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance